Product NDC: | 13668-300 |
Proprietary Name: | LEVETIRACETAM |
Non Proprietary Name: | LEVETIRACETAM |
Active Ingredient(s): | 750 mg/1 & nbsp; LEVETIRACETAM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13668-300 |
Labeler Name: | Torrent Pharmaceuticals Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091338 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120529 |
Package NDC: | 13668-300-25 |
Package Description: | 250 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-300-25) |
NDC Code | 13668-300-25 |
Proprietary Name | LEVETIRACETAM |
Package Description | 250 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-300-25) |
Product NDC | 13668-300 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | LEVETIRACETAM |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120529 |
Marketing Category Name | ANDA |
Labeler Name | Torrent Pharmaceuticals Limited |
Substance Name | LEVETIRACETAM |
Strength Number | 750 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |